AGAMMAGLOBULINEMIA

Clinical trials for AGAMMAGLOBULINEMIA explained in plain language.

Never miss a new study

Get alerted when new AGAMMAGLOBULINEMIA trials appear

Sign up with your email to follow new studies for AGAMMAGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New IVIG therapy V-IMMUNE tested in phase III trial for immune deficiency

Disease control Recruiting now

This phase III trial tests V-IMMUNE, an intravenous immunoglobulin (IVIG) product, in about 50 people with primary immunodeficiency (PID). Participants, aged 2 and older, will switch from their current IVIG to V-IMMUNE every three weeks for a year. The study aims to see if V-IMMU…

Matched conditions: AGAMMAGLOBULINEMIA

Phase: PHASE3 • Sponsor: On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. • Aim: Disease control

Last updated Jun 27, 2026 08:13 UTC

AGAMMAGLOBULINEMIA

Get alerted when new AGAMMAGLOBULINEMIA trials appear

New IVIG therapy V-IMMUNE tested in phase III trial for immune deficiency